roxatidine acetate has been researched along with Curling Ulcer in 14 studies
roxatidine acetate: structure given in first source
Curling Ulcer: Acute stress DUODENAL ULCER, usually observed in patients with extensive third-degree burns.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 9.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
| "Roxatidine acetate is a novel H2-receptor antagonist and several studies have shown that it is effective in healing duodenal ulcers." | 9.08 | Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand. ( Chinapak, O; Kachintorn, U; Khow-ean, U; Kludchareon, N; Kositchaiwat, C; Leethochawalit, M; Lekhayananda, S; Saowaros, V; Suttinont, C; Vongphanich, V, 1995) |
| "A double blind randomised trial, comparing a new H2-receptor antagonist, Roxatidine acetate, with Cimetidine was carried out in 47 patients of uncomplicated, endoscopically proven duodenal ulcer." | 9.07 | New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer. ( Amarapurkar, DN; Desai, HG; Parikh, SS, 1993) |
| " For these reasons, we carried out a prospective pharmacodynamic investigation in 48 patients with endoscopically proven duodenal ulcer using the well-established once daily dosing schedule of H2 blockers." | 6.68 | Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. ( Belicchi, M; Celle, G; Cutela, P; Di Mario, F; Ferrana, M; Malesci, A; Mela, GS; Savarino, V; Termini, R; Vigneri, S; Zentilin, P, 1996) |
| "Roxatidine acetate is a new histamine H2-antagonist of about twice the potency of ranitidine on a weight-for-weight basis." | 6.67 | A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer. ( Collins, M; Cooper, BT; Daneshmend, TK; Hawkey, CJ; Langman, MJ; Logan, RF; Long, RG; Street, R; Walt, RP, 1991) |
| "This study was conducted using roxatidine acetate or Mylanta combined with metronidazole and amoxicillin to evaluate the role of acid and Helicobacter pylori in the natural course of the duodenal ulcer." | 5.09 | The role of gastric acid and Helicobacter pylori in the natural course of duodenal ulcer. ( Chen, WH; Lin, BR; Lin, JT; Wang, JT; Wang, TH; Yang, JC, 1999) |
| "This study reports preliminary results of a controlled, multicenter trial on the quality of ulcer healing induced by lansoprazole (LPZ) or roxatidine (R) in gastric ulcer (GU) or duodenal ulcer (DU) patients." | 5.08 | Quality of peptic ulcer healing induced by lansoprazole and roxatidine. ( Fujino, MA; Kobayashi, K; Morozumi, A; Ohtsuka, H; Sano, S; Suzuki, Y; Tachikawa, H; Uchida, N; Ueda, F; Yamamoto, Y, 1995) |
| "Roxatidine acetate is a novel H2-receptor antagonist and several studies have shown that it is effective in healing duodenal ulcers." | 5.08 | Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand. ( Chinapak, O; Kachintorn, U; Khow-ean, U; Kludchareon, N; Kositchaiwat, C; Leethochawalit, M; Lekhayananda, S; Saowaros, V; Suttinont, C; Vongphanich, V, 1995) |
| "A double blind randomised trial, comparing a new H2-receptor antagonist, Roxatidine acetate, with Cimetidine was carried out in 47 patients of uncomplicated, endoscopically proven duodenal ulcer." | 5.07 | New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer. ( Amarapurkar, DN; Desai, HG; Parikh, SS, 1993) |
| "Healing-promoting actions of KU-1257 (N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea, CAS 120958-90-9) were investigated in chronic gastric and duodenal ulcer models induced by acetic acid in rats and the effects were compared with those of famotidine and roxatidine acetate by gross or histological evaluation." | 3.68 | Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats. ( Aijima, H; Hamada, K; Nishino, K; Sekiguchi, H; Taga, F; Uchida, H, 1993) |
| " Early evening or bedtime dosing with roxatidine 150 mg resulted in similar 4- to 8-week rates of duodenal ulcer healing." | 2.68 | Double-blind, randomized trial of roxatidine 150 mg in the early evening versus bedtime administration in the short-term treatment of duodenal ulcer. ( Bianchi Porro, G; Canali, A; Lazzaroni, M, 1995) |
| "Twenty-four patients with healed duodenal ulcer were dosed according to a balanced incomplete-block design, with two of the following regimens: placebo, roxatidine 150 mg at 07." | 2.68 | Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients. ( Bargiggia, S; Bensi, G; Bianchi Porro, G; Canali, A; Lazzaroni, M; Sangaletti, O, 1996) |
| " For these reasons, we carried out a prospective pharmacodynamic investigation in 48 patients with endoscopically proven duodenal ulcer using the well-established once daily dosing schedule of H2 blockers." | 2.68 | Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. ( Belicchi, M; Celle, G; Cutela, P; Di Mario, F; Ferrana, M; Malesci, A; Mela, GS; Savarino, V; Termini, R; Vigneri, S; Zentilin, P, 1996) |
| "Roxatidine acetate is a new histamine H2-antagonist of about twice the potency of ranitidine on a weight-for-weight basis." | 2.67 | A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer. ( Collins, M; Cooper, BT; Daneshmend, TK; Hawkey, CJ; Langman, MJ; Logan, RF; Long, RG; Street, R; Walt, RP, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujino, MA | 1 |
| Morozumi, A | 1 |
| Kobayashi, K | 1 |
| Ueda, F | 1 |
| Suzuki, Y | 1 |
| Uchida, N | 1 |
| Tachikawa, H | 1 |
| Sano, S | 1 |
| Ohtsuka, H | 1 |
| Yamamoto, Y | 1 |
| Amarapurkar, DN | 1 |
| Parikh, SS | 1 |
| Desai, HG | 1 |
| Bosseckert, H | 1 |
| Ernst, R | 1 |
| Kriech, W | 1 |
| Schunter, C | 1 |
| Sekiguchi, H | 1 |
| Hamada, K | 1 |
| Aijima, H | 1 |
| Taga, F | 1 |
| Uchida, H | 1 |
| Nishino, K | 1 |
| Lazzaroni, M | 2 |
| Canali, A | 2 |
| Bianchi Porro, G | 2 |
| Sangaletti, O | 1 |
| Bargiggia, S | 1 |
| Bensi, G | 1 |
| Savarino, V | 1 |
| Mela, GS | 1 |
| Zentilin, P | 1 |
| Cutela, P | 1 |
| Vigneri, S | 1 |
| Termini, R | 1 |
| Di Mario, F | 1 |
| Ferrana, M | 1 |
| Malesci, A | 1 |
| Belicchi, M | 1 |
| Celle, G | 1 |
| Kachintorn, U | 1 |
| Chinapak, O | 1 |
| Vongphanich, V | 1 |
| Kositchaiwat, C | 1 |
| Lekhayananda, S | 1 |
| Khow-ean, U | 1 |
| Suttinont, C | 1 |
| Saowaros, V | 1 |
| Kludchareon, N | 1 |
| Leethochawalit, M | 1 |
| Yang, JC | 1 |
| Lin, BR | 1 |
| Wang, JT | 1 |
| Chen, WH | 1 |
| Lin, JT | 1 |
| Wang, TH | 1 |
| Gilinsky, NH | 1 |
| Bright-Asare, P | 1 |
| Cobert, BL | 1 |
| Fitch, DD | 1 |
| Lanza, FL | 1 |
| Kerr, RM | 1 |
| Savitsky, JP | 1 |
| Okabe, S | 1 |
| Narita, M | 1 |
| Nakaji, S | 1 |
| Takinami, Y | 1 |
| Kawano, O | 1 |
| Misaki, N | 1 |
| Walt, RP | 1 |
| Logan, RF | 1 |
| Hawkey, CJ | 1 |
| Daneshmend, TK | 1 |
| Long, RG | 1 |
| Cooper, BT | 1 |
| Langman, MJ | 1 |
| Collins, M | 1 |
| Street, R | 1 |
| Kihira, K | 1 |
| Yoshida, Y | 1 |
| Kasano, T | 1 |
| Hirose, M | 1 |
| Sato, K | 1 |
| Hashimoto, M | 1 |
| Kimura, K | 1 |
| Dammann, HG | 1 |
| de Looze, SM | 1 |
| Bender, W | 1 |
| Labs, R | 1 |
1 review available for roxatidine acetate and Curling Ulcer
| Article | Year |
|---|---|
Clinical characteristics of roxatidine acetate: a review.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans | 1988 |
11 trials available for roxatidine acetate and Curling Ulcer
| Article | Year |
|---|---|
Quality of peptic ulcer healing induced by lansoprazole and roxatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal | 1995 |
New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Topics: Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Pip | 1993 |
[Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Female; Histami | 1993 |
Double-blind, randomized trial of roxatidine 150 mg in the early evening versus bedtime administration in the short-term treatment of duodenal ulcer.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulce | 1995 |
Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; | 1996 |
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
Topics: Adult; Analysis of Variance; Drug Tolerance; Duodenal Ulcer; Female; Gastric Acidity Determination; | 1996 |
Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; F | 1995 |
The role of gastric acid and Helicobacter pylori in the natural course of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aluminum Hydroxide; Drug Combinations; Duodenal Ulcer; Female; Gastric Acid | 1999 |
A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal roxatidine in the treatment of active duodenal ulcer disease. Multicenter Roxatidine Cooperative Study Group.
Topics: Abdominal Pain; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Fema | 1992 |
A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
Topics: Adult; Aged; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Piperidine | 1991 |
Clinical characteristics of roxatidine acetate: a review.
Topics: Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; Gastric Acid; Histamine H2 Antagonists; Humans | 1988 |
3 other studies available for roxatidine acetate and Curling Ulcer
| Article | Year |
|---|---|
Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Topics: Acetates; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Famotidine; | 1993 |
[Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Juice; Histami | 1992 |
[Effects of different dosages of roxatidine on 24 hrs intragastric pH].
Topics: Adult; Dose-Response Relationship, Drug; Duodenal Ulcer; Female; Gastric Acidity Determination; Hist | 1989 |